Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Hypertension. 2010 Nov;56(5):839-46. doi: 10.1161/HYPERTENSIONAHA.110.158139. Epub 2010 Sep 7.
Flavanol-rich cocoa products have been reported to lower blood pressure. It has been suggested that theobromine is partially responsible for this effect. We tested whether consumption of flavanol-rich cocoa drinks with natural or added theobromine could lower peripheral and central blood pressure. In a double-blind, placebo-controlled 3-period crossover trial we assigned 42 healthy individuals (age 62±4.5 years; 32 men) with office blood pressure of 130 to 159 mm Hg/85 to 99 mm Hg and low added cardiovascular risk to a random treatment sequence of dairy drinks containing placebo, flavanol-rich cocoa with natural dose consisting of 106 mg of theobromine, or theobromine-enriched flavanol-rich cocoa with 979 mg of theobromine. Treatment duration was 3 weeks with a 2-week washout. The primary outcome was the difference in 24-hour ambulatory systolic blood pressure between placebo and active treatment after 3 weeks. The difference in central systolic blood pressure between placebo and active treatment was a secondary outcome. Treatment with theobromine-enriched cocoa resulted in a mean±SE of 3.2±1.1 mm Hg higher 24-hour ambulatory systolic blood pressure compared with placebo (P<0.01). In contrast, 2 hours after theobromine-enriched cocoa, laboratory peripheral systolic blood pressure was not different from placebo, whereas central systolic blood pressure was 4.3±1.4 mm Hg lower (P=0.001). Natural dose theobromine cocoa did not significantly change either 24-hour ambulatory or central systolic blood pressure compared with placebo. In conclusion, theobromine-enriched cocoa significantly increased 24-hour ambulatory systolic blood pressure while lowering central systolic blood pressure.
富含黄烷醇的可可产品已被报道可降低血压。有人认为可可碱对此效果负有部分责任。我们测试了饮用富含黄烷醇的可可饮料,其中含有天然或添加的可可碱,是否可以降低外周和中心血压。在一项双盲、安慰剂对照的 3 期交叉试验中,我们将 42 名年龄在 62±4.5 岁、办公室血压为 130-159/85-99mmHg、心血管风险较低的健康个体(32 名男性)随机分为 3 组,分别接受含安慰剂的乳制品、含天然剂量(106mg 可可碱)富含黄烷醇的可可或富含可可碱的黄烷醇可可。治疗持续 3 周,洗脱期为 2 周。主要结局是 3 周后,安慰剂和活性治疗之间 24 小时动态收缩压的差异。安慰剂和活性治疗之间中心收缩压的差异是次要结局。与安慰剂相比,富含可可碱的可可治疗导致 24 小时动态收缩压平均升高 3.2±1.1mmHg(P<0.01)。相比之下,富含可可碱的可可治疗后 2 小时,实验室外周收缩压与安慰剂无差异,而中心收缩压则降低 4.3±1.4mmHg(P=0.001)。与安慰剂相比,天然剂量可可碱的可可治疗并未显著改变 24 小时动态或中心收缩压。总之,富含可可碱的可可显著增加了 24 小时动态收缩压,同时降低了中心收缩压。